South Africa Sclerotherapy Market Size & Outlook, 2020-2027
South Africa sclerotherapy market, 2016-2027 (US$M)
Related Markets
South Africa sclerotherapy market highlights
- The South Africa sclerotherapy market generated a revenue of USD 8.4 million in 2020 and is expected to reach USD 11.5 million by 2027.
- The South Africa market is expected to grow at a CAGR of 4.5% from 2021 to 2027.
- In terms of segment, detergents was the largest revenue generating agent in 2020.
- Detergents is the most lucrative agent segment registering the fastest growth during the forecast period.
Sclerotherapy market data book summary
| Market revenue in 2020 | USD 8.4 million |
| Market revenue in 2027 | USD 11.5 million |
| Growth rate | 4.5% (CAGR from 2020 to 2027) |
| Largest segment | Detergents |
| Fastest growing segment | Detergents |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Detergents, Chemical Irritants, Osmotic Agents |
| Key market players worldwide | B2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.9% of the global sclerotherapy market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Middle East & Africa, South Africa sclerotherapy market is projected to lead the regional market in terms of revenue in 2027.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 4.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sclerotherapy Market Scope
Sclerotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa sclerotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.
Detergents was the largest segment with a revenue share of 41.67% in 2020. Horizon Databook has segmented the South Africa sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2016 to 2027.
South Africa was ranked as the unhealthiest country in the world in 2018. The obesity rates in South Africa are alarming as approximately 68% of adult women, 31 % of adult men and 13.3% children under 5 years of age in South African are obese and obesity is considered to be as a driving factor for prevalence of venous conditions.
South Africa is one of the highest growing country in terms of population, is considered first-tier emerging market economies. According to the Global Health Report, by 2030, 23.6 million South African Adults will have diabetes more than the number of people with HIV currently, and multi morbidity is one the rise too.
According to article published by BMC Geriatrics, South Africa has the highest proportion of elderly people in its population in the African region (8.7%) and the number of elderly people over 60 years is expected to increase from 4.1 million in 2011 to over 15 million in 2030.
Reasons to subscribe to South Africa sclerotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa sclerotherapy market databook
-
Our clientele includes a mix of sclerotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa sclerotherapy market, including forecasts for subscribers. This country databook contains high-level insights into South Africa sclerotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa sclerotherapy market size, by agent, 2016-2027 (US$M)
South Africa Sclerotherapy Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
